Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$86.24 - $95.92 $284,678 - $316,631
-3,301 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $51,456 - $64,811
-768 Reduced 18.87%
3,301 $241,000
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $224,730 - $325,235
4,069 New
4,069 $316,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Alphasimplex Group, LLC Portfolio

Follow Alphasimplex Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphasimplex Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alphasimplex Group, LLC with notifications on news.